clonacell-hy selection medium e (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
clonacell-hy selection medium e
Clonacell Hy Selection Medium E, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+medium/clonacell+hy+selection+medium+d/us11077202-559-14-18
Average 90 stars, based on 1 article reviews
Clonacell Hy Selection Medium E, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+medium/clonacell+hy+selection+medium+d/us11077202-559-14-18
Average 90 stars, based on 1 article reviews
clonacell-hy selection medium e - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Selection:Article Title: Anti-GARP antibody Article Snippet: For example, a hybridoma group formed by cell fusion is suspended in a methyl cellulose medium such as Article Title: Anti-SIRPalpha antibody Article Snippet: 1)-4 Preparation of Hybridoma Lymph node cells or spleen cells were electrofused with mouse myeloma SP2/0-ag14 cells (ATCC, CRL-1581) using LF301-Cell Fusion Unit (BEX), and the fused cells were diluted and cultured in Article Title: Anti-SIRPalpha antibody Article Snippet: First, each antibody-producing hybridoma was proliferated to a sufficient amount using Article Title: Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate Article Snippet: For example, the group of hybridomas produced by cell fusion are suspended in a methylcellulose medium such as Article Title: LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy Article Snippet: Clonal hybridoma cells were cultured in Article Title: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer Article Snippet: A2780 cell line was purchased from NCI-DCTD tumor repository and A2780 cisplatin-resistant (A2780-CisR) human ovarian cancer cell lines was purchased from European Collection of Authenticated Cell Cultures (ECACC)-Sigma Aldrich. Cell Culture:Article Title: Anti-GARP antibody Article Snippet: For example, a hybridoma group formed by cell fusion is suspended in a methyl cellulose medium such as Article Title: Anti-SIRPalpha antibody Article Snippet: 1)-4 Preparation of Hybridoma Lymph node cells or spleen cells were electrofused with mouse myeloma SP2/0-ag14 cells (ATCC, CRL-1581) using LF301-Cell Fusion Unit (BEX), and the fused cells were diluted and cultured in Article Title: Anti-SIRPalpha antibody Article Snippet: First, each antibody-producing hybridoma was proliferated to a sufficient amount using Article Title: Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate Article Snippet: For example, the group of hybridomas produced by cell fusion are suspended in a methylcellulose medium such as Article Title: LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy Article Snippet: Clonal hybridoma cells were cultured in Article Title: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer Article Snippet: A2780 cell line was purchased from NCI-DCTD tumor repository and A2780 cisplatin-resistant (A2780-CisR) human ovarian cancer cell lines was purchased from European Collection of Authenticated Cell Cultures (ECACC)-Sigma Aldrich. Incubation:Article Title: Anti-GARP antibody Article Snippet: For example, a hybridoma group formed by cell fusion is suspended in a methyl cellulose medium such as Article Title: Anti-SIRPalpha antibody Article Snippet: 1)-4 Preparation of Hybridoma Lymph node cells or spleen cells were electrofused with mouse myeloma SP2/0-ag14 cells (ATCC, CRL-1581) using LF301-Cell Fusion Unit (BEX), and the fused cells were diluted and cultured in Article Title: Anti-SIRPalpha antibody Article Snippet: First, each antibody-producing hybridoma was proliferated to a sufficient amount using Article Title: Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate Article Snippet: For example, the group of hybridomas produced by cell fusion are suspended in a methylcellulose medium such as Article Title: LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy Article Snippet: Clonal hybridoma cells were cultured in Article Title: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer Article Snippet: A2780 cell line was purchased from NCI-DCTD tumor repository and A2780 cisplatin-resistant (A2780-CisR) human ovarian cancer cell lines was purchased from European Collection of Authenticated Cell Cultures (ECACC)-Sigma Aldrich. Produced:Article Title: Anti-GARP antibody Article Snippet: For example, a hybridoma group formed by cell fusion is suspended in a methyl cellulose medium such as Article Title: Anti-SIRPalpha antibody Article Snippet: 1)-4 Preparation of Hybridoma Lymph node cells or spleen cells were electrofused with mouse myeloma SP2/0-ag14 cells (ATCC, CRL-1581) using LF301-Cell Fusion Unit (BEX), and the fused cells were diluted and cultured in Article Title: Anti-SIRPalpha antibody Article Snippet: First, each antibody-producing hybridoma was proliferated to a sufficient amount using Article Title: Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate Article Snippet: For example, the group of hybridomas produced by cell fusion are suspended in a methylcellulose medium such as Article Title: LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy Article Snippet: Clonal hybridoma cells were cultured in Article Title: Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer Article Snippet: A2780 cell line was purchased from NCI-DCTD tumor repository and A2780 cisplatin-resistant (A2780-CisR) human ovarian cancer cell lines was purchased from European Collection of Authenticated Cell Cultures (ECACC)-Sigma Aldrich. |
